Zdrowie i gospodarka · 16/03/2017

Public Meeting on Patient-Focused Drug Development for Sarcopenia; Request for Comments; Correction

The Food and Drug Administration is correcting a notice entitled "Public Meeting on Patient-Focused Drug Development for Sarcopenia" that appeared in the Federal Register of December 14, 2016 (81 FR 90361). The document announced a public meeting and an opportunity for public comment on Patient-Focused Drug Development for Sarcopenia. The location of the meeting has changed and this document provides the updated meeting location.